Arbutus Biopharma Corp Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Arbutus Biopharma Corp quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q2 2024.
  • Arbutus Biopharma Corp Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 189M shares, a 13.1% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 189M +21.8M +13.1% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 180M +15.1M +9.12% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 170M +12.4M +7.88% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 168M +15M +9.81% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 167M +18.1M +12.2% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 165M +16.4M +11% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 157M +12.5M +8.6% Dec 31, 2022 10-K 2024-03-05
Q3 2022 153M +42.4M +38.5% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 149M +51.1M +52.3% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 149M +52.5M +54.5% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 145M +55.3M +61.7% Dec 31, 2021 10-K 2023-03-02
Q3 2021 110M +25.6M +30.3% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 97.7M +26.4M +37.1% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 96.2M +39.4M +69.3% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 89.7M +24.9M +38.4% Dec 31, 2020 10-K 2022-03-03
Q3 2020 84.6M +27.8M +48.8% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 71.3M +14.4M +25.3% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 56.9M +594K +1.06% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 64.8M +9.26M +16.7% Dec 31, 2019 10-K 2021-03-04
Q3 2019 56.9M +1.38M +2.48% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 56.9M +1.52M +2.76% Jun 30, 2019 10-Q 2019-08-05
Q1 2019 56.3M +1.17M +2.12% Mar 31, 2019 10-Q 2019-05-06
Q4 2018 55.5M +458K +0.83% Dec 31, 2018 10-K 2020-03-05
Q3 2018 55.5M +420K +0.76% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 55.3M +298K +0.54% Jun 30, 2018 10-Q 2018-08-03
Q1 2018 55.1M +62.6K +0.11% Mar 31, 2018 10-Q 2018-05-04
Q4 2017 55.1M +219K +0.4% Dec 31, 2017 10-K 2019-03-07
Q3 2017 55.1M +210K +0.38% Sep 30, 2017 10-Q 2017-11-02
Q2 2017 55M +230K +0.42% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 55M +399K +0.73% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 54.8M +271K +0.5% Dec 31, 2016 10-K 2018-03-16
Q3 2016 54.8M +272K +0.5% Sep 30, 2016 10-Q 2016-11-03
Q2 2016 54.8M +493K +0.91% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 54.6M +530K +0.98% Mar 31, 2016 10-Q 2016-05-04
Q4 2015 54.6M +32.1M +143% Dec 31, 2015 10-K 2017-03-22
Q3 2015 54.6M +32.3M +145% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 54.3M +32.2M +146% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 54.1M +32.1M +146% Mar 31, 2015 10-Q 2015-05-06
Q4 2014 22.4M +3.39M +17.8% Dec 31, 2014 10-K 2016-03-09
Q3 2014 22.3M Sep 30, 2014 10-Q 2014-11-07
Q2 2014 22.1M Jun 30, 2014 10-Q 2014-08-14
Q1 2014 22M Mar 31, 2014 10-Q 2014-05-14
Q4 2013 19M +4.74M +33.2% Dec 31, 2013 10-K 2015-03-13
Q4 2012 14.3M +2.16M +17.8% Dec 31, 2012 10-K 2014-03-28
Q4 2011 12.1M +1.81M +17.5% Dec 31, 2011 20-F 2013-03-27
Q4 2010 10.3M Dec 31, 2010 20-F 2012-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.